Wuhan Easy Diagnosis Biomedicine Co.,Ltd.’s Net Profit Rose 308.7% in First Quarter of 2022

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (武汉明德生物科技股份有限公司) (002932.SZ) reported a net profit of 1.4 billion yuan in the first quarter of 2022, up 308.7% year-on-year.

Meanwhile, the company posted 2.5 billion yuan in revenue, up 267.4% year-on-year.

At the end of the reporting period, it had 5.3 billion yuan in total assets and 1 billion yuan in total liabilities, with a liability-to-asset ratio of 18.3%.